Despite federal COVID funding inaction, Indiana still has plenty left to spend
Indiana still has 43% of its $1 billion-plus in federal COVID-19 grants left to spend, according to Indiana State Department of Health data.
Moderna sues Pfizer over patents behind COVID-19 vaccine
COVID-19 vaccine maker Moderna accuses competitors Pfizer and BioNTech of copying Moderna’s technology in order to make their own vaccine.
Study: Pfizer COVID pill showed no benefit in younger adults
The researchers found that Paxlovid reduced hospitalizations among people 65 and older by roughly 75% when given shortly after infection. But people between the ages of 40 and 65 saw no measurable benefit, according to the analysis of medical records.
IRS to wipe away $1.2 billion in late fees from pandemic
The IRS estimates that nearly 1.6 million taxpayers will receive more than $1.2 billion worth of penalty relief. The tax agency will automatically issue the refunds or credits for most of the fees by the end of September.
Pfizer seeks OK of updated COVID vaccine booster for fall
Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives—a key step toward opening a fall booster campaign.
Remote work revolution already reshaping America
Remote work has stabilized at an extraordinarily high level: Around a third of work was done remotely in the United States in 2021 and 2022, according to several economists.
Conrad Indianapolis hotel loses appeal for COVID-19 insurance payout
In 2020, occupancy rates at the Conrad dropped “into the single digits” due to the COVID-19 pandemic. The hotel “lost virtually all of its business income” while incurring “additional expenses for cleaning and disinfecting the property.”
CDC drops quarantine, screening recommendations for COVID-19
The changes are driven by a recognition that an estimated 95% of Americans 16 and older have acquired some level of immunity, either from being vaccinated or infected, agency officials said.
COVID-disrupted grads face college: ‘I didn’t really learn anything’
After the disruption of online learning, first-year college students are arriving arrive on U.S. campuses unprepared for the demands of college-level work, experts say.
U.S. reaches deal with Moderna for omicron COVID-19 vaccine
The agreement with Moderna calls for the United States to buy 66 million doses of the company’s next generation COVID-19 vaccine, which targets the highly transmissible omicron variant, enough supply this winter for
Pandemic brings yearning for immersive internships
Two years after COVID-19 shutdowns, companies, students and professionals are still deciphering how to move forward with workplace changes, including the internship experience.
New studies bolster theory coronavirus emerged from the wild
The research, published online Tuesday by the journal Science, shows that the Huanan Seafood Wholesale Market was likely the early epicenter of the scourge that has now killed nearly 6.4 million people around the world.
Biden tests positive for COVID, has mild symptoms, White House says
President Joe Biden, 79, has begun taking Pfizer’s Paxlovid treatment for the disease, Press Secretary Karine Jean-Pierre said, and will isolate at the White House while continuing his duties.
CDC endorses more traditional Novavax COVID shot for adults
Health officials say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax. The protein-based shot is a more traditional kind of vaccine than the three brands available.
25M children missed routine vaccinations because of COVID
Experts said this “historic backsliding” in vaccination coverage was especially disturbing since it was occurring as rates of severe malnutrition were rising.
U.S. regulators approve new COVID-19 vaccine option
Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.—and one that’s already available in Europe and multiple other countries.
Pandemic fueled surge in superbug infections, deaths, CDC says
The surge reversed years of progress fighting one of the gravest public health challenges in modern medicine, according to a new analysis released Tuesday by the Centers for Disease Control and Prevention.
Biden officials push to offer second booster shots to all adults
Virus levels have risen across the country, fueled by ever-more-contagious omicron subvariants such as BA. 5 that evade some immune protections and have increased the risk of reinfections.
Latest variant driving new wave of coronavirus infections
Officials warn of a possible fall or winter wave—perhaps as many as 100 million infections in the United States—that could again flood hospitals with COVID patients.
U.S. allows pharmacists to prescribe Pfizer’s COVID-19 pill
The announcement comes as COVID-19 cases, hospitalizations and deaths are rising again, although they remain near their lowest levels since the coronavirus outbreak began in 2020.
Resources
Centers for Disease Control and Prevention CDC Resources for Businesses and Employers OSHA Guidance on Preparing Workplaces for COVID-19 Indiana State Department of Health Indy Chamber Rapid Response Hub Small Business Administration The SBA is making low-interest loans for working capital available to Indiana small businesses. Indiana Unemployment Information Johns Hopkins Coronavirus Dashboard Critical Industries Hotline(for business and industry only)
877-820-0890
[email protected] State’s virus-related executive orders State plan to reopen Indiana